LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers Squibb/Orbital Therapeutics. Validating LNPs as a stand-out delivery vehicle for cell and gene therapies!

Time: 8:00 AM – 5:00 PM

Venue Details: The Westin Boston Seaport District, 425 Summer Street, Boston, Massachusetts, 02210, United States